Comparison of non-bismuth concomitant and standard triple therapies as a first-line treatment option for Helicobacter pylori in Japa
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000018164
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded from the study if they were younger than 20 years or older than 80 years, were allergic to the drugs used in this therapy. Patients who are disqualified for the study by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the eradication rate of the two regimens, PPI+AMPC +CAM+MNZ versus PPI+AMPC+CAM for first line
- Secondary Outcome Measures
Name Time Method Comparison of the safety of the two regimens, PPI+AMPC +CAM+MNZ versus PPI+AMPC+CAM for first line